Rise Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $73.9K | Sell |
166
-1
| -0.6% | -$445 | 0.03% | 191 |
|
|
2025
Q1 | $81K | Buy |
167
+14
| +9% | +$6.79K | 0.04% | 169 |
|
|
2024
Q4 | $61.6K | Sell |
153
-5
| -3% | -$2.01K | 0.03% | 195 |
|
|
2024
Q3 | $73.5K | Buy |
158
+2
| +1% | +$930 | 0.04% | 173 |
|
|
2024
Q2 | $73.1K | Hold |
156
| – | – | 0.04% | 180 |
|
|
2024
Q1 | $65.2K | Buy |
156
+151
| +3,020% | +$63.1K | 0.03% | 187 |
|
|
2023
Q4 | $2.03K | Hold |
5
| – | – | ﹤0.01% | 466 |
|
|
2023
Q3 | $1.74K | Hold |
5
| – | – | ﹤0.01% | 485 |
|
|
2023
Q2 | $1.76K | Hold |
5
| – | – | ﹤0.01% | 531 |
|
|
2023
Q1 | $1.58K | Hold |
5
| – | – | ﹤0.01% | 598 |
|
|
2022
Q4 | $1.44K | Hold |
5
| – | – | ﹤0.01% | 610 |
|
|
2022
Q3 | $1K | Hold |
5
| – | – | ﹤0.01% | 688 |
|
|
2022
Q2 | $1K | Hold |
5
| – | – | ﹤0.01% | 686 |
|
|
2022
Q1 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 644 |
|